Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Fumiyoshi Kobayashi"'
Publikováno v:
Journal of Sustainable Metallurgy. 8:1498-1508
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c87631942f3036d01e8aedf01e7dd894
https://doi.org/10.1007/s40831-022-00617-6
https://doi.org/10.1007/s40831-022-00617-6
Variational quantum eigensolver (VQE), which attracts attention as a promising application of noisy intermediate-scale quantum devices, finds a ground state of a given Hamiltonian by variationally optimizing the parameters of quantum circuits called
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef5c5e3e360e9d18aef69bb2786ceda9
Publikováno v:
Arzneimittelforschung. 57:92-100
Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) is an antagonist for the muscarinic acetylcholine (ACh) receptor currently under development for the treatment of overactive bladder. Affinities of imidafenacin and other drugs for muscarinic ACh rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a12a5b20712efc33cffc0e482542149
https://doi.org/10.1055/s-0031-1296589
https://doi.org/10.1055/s-0031-1296589
Autor:
Mitsuru Segawa, Shigeki Matsuzawa, Takanobu Yamazaki, Eiji Wakabayashi, Fumiyoshi Kobayashi, Masako Inoue, Yuichi Yageta
Publikováno v:
Arzneimittelforschung. 57:147-154
Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) has been developed for the treatment of overactive bladder as a new anti-cholinergic with high affinities for muscarinic acetylcholine M3 and M1 receptors. The pharmacological profiles of imidafenacin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f03a39d3d3fdba4602e2281d63969e2
https://doi.org/10.1055/s-0031-1296598
https://doi.org/10.1055/s-0031-1296598
Publikováno v:
Transactions of the Japanese Society for Artificial Intelligence. 26:341-346
Model checking is an exhaustive search method of verification. Automata-based LTL model checking is one of the methods to solve accepting cycle search problems. Model checking is prone to state-space explosion, and we may expect that parallel process
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ccee65b460d4e4102fcffa026fd141a
https://doi.org/10.1527/tjsai.26.341
https://doi.org/10.1527/tjsai.26.341
Publikováno v:
European Journal of Pharmacology. 487:7-15
Carbocisteine is a mucoregulatory drug regulating fucose and sialic acid contents in mucus glycoprotein. To investigate the mechanism of carbocisteine action, we evaluated the effects of carbocisteine on the activity of fucosidase, sialidase, fucosyl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3374fee2e7f5ddc1a8b03c064e0d53cb
https://doi.org/10.1016/j.ejphar.2003.12.038
https://doi.org/10.1016/j.ejphar.2003.12.038
Autor:
Reiko Shiba, Hiroshi Muto, Kenjiro Momo, Fumiyoshi Kobayashi, Hirofumi Matsui, Yasushii Murata, Akira Nakahara, Yoshifusa Kondo
Publikováno v:
Digestive Diseases and Sciences. 46:338-344
We previously reported that the gastric mucosa emits fluorescence of porphyrins at the onset of gastric lesions induced by hemorrhagic shock. In this study, we investigated whether the fluorescent substance concerns with the gastric mucosal injuries
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::303b0a6302dd28c020bc14f24f0ad67e
https://doi.org/10.1023/a:1005656916830
https://doi.org/10.1023/a:1005656916830
Publikováno v:
Folia Pharmacologica Japonica. 107:67-78
The influence of KU-1257 on the recurrence and relapse of acetic acid ulcers in rats was investigated grossly and histologically in comparison with that of cimetidine. The ulcer was induced by topical application of glacial acetic acid at the junctio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4926f40c4c8951ef97b01bcfbd2192c2
https://doi.org/10.1254/fpj.107.67
https://doi.org/10.1254/fpj.107.67
Publikováno v:
Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 131(5)
イミダフェナシン（ウリトス®錠，ステーブラ®錠）は，過活動膀胱を適応症として2007年6月に国内で上市された新規抗ムスカリン薬である．ムスカリン受容体サブタイプ選択性に特徴が
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e74077e80bb5f4603a46177078f621f
https://pubmed.ncbi.nlm.nih.gov/18480570
https://pubmed.ncbi.nlm.nih.gov/18480570
Autor:
Fumiyoshi, Kobayashi, Yuichi, Yageta, Takanobu, Yamazaki, Eiji, Wakabayashi, Masako, Inoue, Mitsuru, Segawa, Shigeki, Matsuzawa
Publikováno v:
Arzneimittel-Forschung. 57(3)
Imidafenacin (CAS 170105-16-5, KRP-197, ONO-8025) has been developed for the treatment of overactive bladder as a new anti-cholinergic with high affinities for muscarinic acetylcholine M3 and M1 receptors. The pharmacological profiles of imidafenacin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef9d0982c9fdfc3726abb6631ebaa405
https://pubmed.ncbi.nlm.nih.gov/17469649
https://pubmed.ncbi.nlm.nih.gov/17469649